GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Series GSE78124
Query DataSets for GSE78124
Status
Public on Jun 01, 2016
Title
Insulin-Like Growth Factor Receptor 1 and Mammalian Target Of Rapamycin Blockade: Novel Mechanisms of Resistance and Synergistic Drug Combinations for Ewing Sarcoma
Organism
Homo sapiens
Experiment type
Protein profiling by protein array
Summary
This SuperSeries is composed of the SubSeries listed below.
Overall design
Refer to individual Series
Citation(s)
27576731
Submission date
Feb 19, 2016
Last update date
Sep 06, 2016
Contact name
Joseph A. Ludwig
E-mail(s)
jaludwig@mdanderson.org
Phone
713-792-4265
Organization name
UT-MD-Anderson Cancer Center
Department
Sarcoma Medical Oncology
Lab
Sarcoma Medical Oncology
Street address
4SCR2-1042 1901 East Rd
City
Houston
State/province
Texas
ZIP/Postal code
77054
Country
USA
Platforms (3)
GPL21488
In vitro proteomic expression changes in Ewing sarcoma cell lines after IGF-1R or IGF-1R/IR blockade
GPL21489
In vitro proteomic expression changes in Ewing sarcoma cell lines after mTOR blockade
GPL21490
In vivo proteomic expression changes in EW5 Ewing sarcoma xenografts after IGF-1R and/or mTOR blockade
Samples (54)
Less...
More...
GSM2067599
TC32: Parental-Rep2
GSM2067600
TC71: Parental-Rep2
GSM2067601
TC71: Parental-Rep3
GSM2067602
TC32: NVP-ADW-742-Selected-CP
GSM2067603
TC32: NVP-ADW-742-Selected-C1
GSM2067604
TC32: NVP-ADW-742-Selected-C9
GSM2067605
TC71: NVP-ADW-742-Selected-C2
GSM2067606
TC32: OSI906-Selected-CP
GSM2067607
TC32: OSI906-Selected-C4
GSM2067608
TC32: OSI906-Selected-C5
GSM2067609
TC71: OSI906-Selected-C4
GSM2067610
TC71: OSI906-Selected-C6
GSM2067611
TC71: OSI906-Selected-C7
GSM2067612
TC32: Parental-Rep3
GSM2067613
TC71: Parental-Rep4
GSM2067614
TC71: NVP-ADW-742-Selected-C1
GSM2067615
TC71: NVP-ADW-742-Selected-C6
GSM2067616
TC71: Parental-NVP-ADW-742-72hrs
GSM2067617
TC32: Parental-NVP-ADW-742-72hrs
GSM2067618
TC71: Parental-OSI906-72hrs
GSM2067619
TC32: Parental-OSI906-72hrs
GSM2067620
TC71: Parental-Rep5
GSM2067621
TC32: Parental-Rep4
GSM2067622
TC32: Parental-Rep5
GSM2067623
TC71: Parental-Ridaforolimus-72hrs
GSM2067624
TC32: Parental-Ridaforolimus-72hrs
GSM2067625
TC71: Parental_Rep-1
GSM2067626
TC32: Parental_Rep1
GSM2067627
TC32: Parental_Rep2
GSM2067628
TC32: Ridaforolimus-Selected-C6
GSM2067629
TC32: Ridaforolimus-Selected-C7
GSM2067630
TC32: Ridaforolimus-Selected-C8
GSM2067631
TC32: Ridaforolimus-Selected-C9
GSM2067632
TC71: Ridaforolimus-Selected-C1.1
GSM2067633
TC71: Ridaforolimus-Selected-C1.2
GSM2067634
TC71: Ridaforolimus-Selected-C1.3
GSM2067635
TC71: Ridaforolimus-Selected-C1.4
GSM2067636
Combination: 23
GSM2067637
Ridaforolimus: 25
GSM2067638
Dalotuzumab: 30
GSM2067639
Control: 39
GSM2067640
Ridaforolimus: 42
GSM2067641
Dalotuzumab: 45
GSM2067642
Ridaforolimus: 49
GSM2067643
Combination: 51
GSM2067644
Combination: 52
GSM2067645
Control: 55
GSM2067646
Ridaforolimus: 61
GSM2067647
Dalotuzumab: 62
GSM2067648
Combination: 66
GSM2067649
Dalotuzumab: 17
GSM2067650
Dalotuzumab: 21
GSM2067651
Control: 58
GSM2067652
Combination: 44
This SuperSeries is composed of the following SubSeries:
GSE78121
In vitro proteomic expression changes in Ewing sarcoma cell lines after IGF-1R or IGF-1R/IR blockade
GSE78122
In vitro proteomic expression changes in Ewing sarcoma cell lines after mTOR blockade
GSE78123
In vivo proteomic expression changes in EW5 Ewing sarcoma xenografts after IGF-1R and/or mTOR blockade
Relations
BioProject
PRJNA312656
Download family
Format
SOFT formatted family file(s)
SOFT
MINiML formatted family file(s)
MINiML
Series Matrix File(s)
TXT
Supplementary data files not provided
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|
Less...
More...